data_1ccm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ccm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.864 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.527 0.145 0 CA-C-O 121.582 0.576 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 123.669 1.7 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 115.476 1.299 . . . . 0.0 115.476 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.9 p . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 122.365 1.079 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.033 -0.795 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 123.721 1.724 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 CA--C 1.552 1.383 0 N-CA-C 115.367 1.257 . . . . 0.0 115.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 125.653 2.644 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.547 1.143 0 N-CA-C 115.578 1.338 . . . . 0.0 115.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 124.092 1.901 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.536 0.603 0 N-CA-C 116.841 1.823 . . . . 0.0 116.841 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 0 CA--C 1.542 0.885 0 CA-C-O 122.388 0.912 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 5.9 tpt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.541 0.857 0 N-CA-C 114.282 0.839 . . . . 0.0 114.282 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.2 p -77.36 51.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 112.026 -2.352 . . . . 0.0 114.938 -165.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.864 0.0 OUTLIER -57.25 -24.17 52.94 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.267 30.8 mt -71.17 -59.79 3.14 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-O 115.814 -2.041 . . . . 0.0 112.776 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -81.71 -69.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.445 2.096 . . . . 0.0 114.124 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.22 37.47 2.19 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 127.392 2.425 . . . . 0.0 112.444 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.384 56.1 m -8.51 -71.71 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 129.472 3.109 . . . . 0.0 115.594 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -50.2 131.19 30.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 CA-C-N 122.327 1.867 . . . . 0.0 112.449 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 120.446 3.499 . . . . 0.0 120.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.5 p -89.45 59.47 4.81 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.99 2.116 . . . . 0.0 111.851 -169.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 -105.39 16.5 25.48 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.17 -40.16 74.92 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -44.57 34.53 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.174 2.582 . . . . 0.0 115.803 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.76 45.88 5.89 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.368 1.461 . . . . 0.0 111.476 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.323 2.9 m -148.78 -68.39 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.377 -1.297 . . . . 0.0 113.114 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.67 62.87 8.39 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 CA-C-N 122.348 1.874 . . . . 0.0 115.476 -162.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.9 p -77.35 120.19 22.03 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 110.306 -3.134 . . . . 0.0 108.251 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -114.76 31.79 6.42 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.56 -47.91 45.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.918 159.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.71 176.09 10.26 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.145 1.23 . . . . 0.0 110.036 165.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.56 27.61 1.56 Allowed Glycine 0 CA--C 1.548 2.12 0 C-N-CA 126.163 1.84 . . . . 0.0 114.226 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 m -53.18 133.5 51.03 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 127.042 2.137 . . . . 0.0 110.74 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -61.17 132.88 43.74 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 121.101 1.201 . . . . 0.0 110.033 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.481 1.122 1 N-CA-C 125.654 5.427 . . . . 0.0 125.654 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.4 p -101.55 60.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.429 -168.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.41 23.42 13.62 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.94 -40.29 80.24 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 116.459 -1.734 . . . . 0.0 114.941 174.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.17 -68.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.752 1.635 . . . . 0.0 111.217 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.19 65.6 0.16 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 127.02 2.248 . . . . 0.0 112.343 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.347 16.2 m -147.14 -71.3 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.39 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -82.2 61.72 7.83 Favored 'Trans proline' 0 CA--C 1.552 1.383 0 CA-C-N 121.994 1.748 . . . . 0.0 115.367 -164.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.391 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 124.727 2.203 . . . . 0.0 116.045 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -110.85 73.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 110.736 -2.938 . . . . 0.0 108.323 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -85.54 3.86 38.61 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.7 mt -51.2 -41.43 75.01 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 122.931 2.605 . . . . 0.0 114.667 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -67.89 -49.86 0.97 Allowed 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 121.581 1.521 . . . . 0.0 110.997 166.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.14 -33.65 5.47 Favored Glycine 0 N--CA 1.494 2.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.392 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.281 82.1 m -61.14 -70.39 0.45 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 127.214 2.206 . . . . 0.0 114.616 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.0 71.81 6.86 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 CA-C-N 121.61 1.611 . . . . 0.0 115.578 -157.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.491 1.618 1 N-CA-C 125.248 5.277 . . . . 0.0 125.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.6 p -101.87 60.19 0.86 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.334 -169.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 8.94 44.26 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.54 -41.42 76.95 Favored Pre-proline 0 N--CA 1.481 1.11 0 CA-C-O 116.303 -1.808 . . . . 0.0 114.446 167.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.38 -46.7 29.9 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.868 3.045 . . . . 0.0 115.054 170.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.84 4.82 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.582 1.563 . . . . 0.0 113.675 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.343 2.4 m -149.47 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.65 70.11 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 116.841 -159.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.5 p -79.45 130.52 35.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.382 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 -97.07 40.71 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.9 mt -56.17 125.96 66.07 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 147.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 0.24 -65.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 2 C-N-CA 126.615 4.876 . . . . 0.0 124.098 -173.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.94 -32.24 83.34 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.462 1.03 . . . . 0.0 115.595 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -77.17 130.19 75.87 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 124.759 0.917 . . . . 0.0 113.058 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -68.69 141.26 49.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.136 1.891 . . . . 0.0 111.444 172.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 122.165 0.983 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.8 p -102.51 68.66 1.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 5.9 tpt180 -95.82 11.51 33.39 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.56 -43.03 97.53 Favored Pre-proline 0 N--CA 1.483 1.206 0 CA-C-O 116.422 -1.752 . . . . 0.0 113.437 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -57.34 -63.88 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.742 2.295 . . . . 0.0 112.671 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.83 53.94 0.24 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 113.193 -1.821 . . . . 0.0 114.84 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.308 3.3 m -154.55 -69.28 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 117.474 -1.25 . . . . 0.0 113.546 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.66 73.87 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.847 1.695 . . . . 0.0 114.282 -160.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.51 HG22 HG12 ' A' ' 34' ' ' ILE . 60.2 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 35' ' ' ILE . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.744 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 17' ' ' ARG 0.864 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.527 0.145 0 CA-C-O 121.582 0.576 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 44' ' ' TYR . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 2' ' ' THR . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.744 HD21 ' NH1' ' A' ' 10' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 123.669 1.7 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.687 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 56.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 115.476 1.299 . . . . 0.0 115.476 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 44' ' ' TYR . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.479 HG22 HG12 ' A' ' 34' ' ' ILE . 55.9 p . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 122.365 1.079 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HB2' HD13 ' A' ' 25' ' ' LEU . 77.1 Cg_exo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.033 -0.795 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 22' ' ' PRO . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 2' ' ' THR . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' HD11 ' A' ' 35' ' ' ILE . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.498 ' CD2' HG12 ' A' ' 33' ' ' ILE . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 34' ' ' ILE . 81.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 123.721 1.724 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.682 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 51.1 Cg_endo . . . . . 0 CA--C 1.552 1.383 0 N-CA-C 115.367 1.257 . . . . 0.0 115.367 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.625 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 17' ' ' ARG . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 2' ' ' THR . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' A' ' 33' ' ' ILE . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.682 HD21 ' NH1' ' A' ' 10' ' ' ARG 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.844 HG22 HD13 ' A' ' 34' ' ' ILE . 19.9 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 125.653 2.644 . . . . 0.0 108.323 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.525 ' HZ ' HD11 ' A' ' 34' ' ' ILE . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 6.5 mmm-85 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.6 Cg_endo . . . . . 0 CA--C 1.547 1.143 0 N-CA-C 115.578 1.338 . . . . 0.0 115.578 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 17' ' ' ARG . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 44' ' ' TYR . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 HG22 ' A' ' 2' ' ' THR . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' HD11 ' A' ' 35' ' ' ILE . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 34' ' ' ILE . 54.6 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 124.092 1.901 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.683 ' CZ ' HD21 ' A' ' 46' ' ' ASN . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 61.2 Cg_endo . . . . . 0 CA--C 1.536 0.603 0 N-CA-C 116.841 1.823 . . . . 0.0 116.841 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HE1' ' A' ' 44' ' ' TYR . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 2' ' ' THR . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.494 ' HE1' ' O ' ' A' ' 31' ' ' GLY . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.683 HD21 ' CZ ' ' A' ' 10' ' ' ARG . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 34' ' ' ILE . 75.5 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 35' ' ' ILE . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' HH11 ' A' ' 10' ' ' ARG . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 HH11 ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HB2' HD23 ' A' ' 25' ' ' LEU . 43.8 Cg_exo . . . . . 0 CA--C 1.542 0.885 0 CA-C-O 122.388 0.912 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 22' ' ' PRO . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 44' ' ' TYR . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 2' ' ' THR . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 3' ' ' CYS . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 34' ' ' ILE . 69.8 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 6' ' ' SER . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HD3' ' OE2' ' A' ' 23' ' ' GLU 0.286 5.9 tpt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.668 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.2 Cg_endo . . . . . 0 CA--C 1.541 0.857 0 N-CA-C 114.282 0.839 . . . . 0.0 114.282 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 ' CD2' ' A' ' 44' ' ' TYR . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 2' ' ' THR . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' HG12 ' A' ' 33' ' ' ILE . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.51 HG22 HG12 ' A' ' 34' ' ' ILE . 60.2 p -77.36 51.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 112.026 -2.352 . . . . 0.0 114.938 -165.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 35' ' ' ILE . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.744 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.549 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 17' ' ' ARG 0.864 0.0 OUTLIER -57.25 -24.17 52.94 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.267 30.8 mt -71.17 -59.79 3.14 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-O 115.814 -2.041 . . . . 0.0 112.776 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 15' ' ' VAL . 50.8 Cg_endo -81.71 -69.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.445 2.096 . . . . 0.0 114.124 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.22 37.47 2.19 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 127.392 2.425 . . . . 0.0 112.444 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ARG 0.384 56.1 m -8.51 -71.71 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 129.472 3.109 . . . . 0.0 115.594 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -50.2 131.19 30.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 CA-C-N 122.327 1.867 . . . . 0.0 112.449 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 44' ' ' TYR . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 2' ' ' THR . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.744 HD21 ' NH1' ' A' ' 10' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' ALA . 48.4 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 120.446 3.499 . . . . 0.0 120.446 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 1' ' ' THR . 65.5 p -89.45 59.47 4.81 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.99 2.116 . . . . 0.0 111.851 -169.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 -105.39 16.5 25.48 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.17 -40.16 74.92 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -44.57 34.53 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.174 2.582 . . . . 0.0 115.803 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.76 45.88 5.89 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.368 1.461 . . . . 0.0 111.476 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.323 2.9 m -148.78 -68.39 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.377 -1.297 . . . . 0.0 113.114 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.687 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -81.67 62.87 8.39 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 CA-C-N 122.348 1.874 . . . . 0.0 115.476 -162.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 44' ' ' TYR . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 1' ' ' THR . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.479 HG22 HG12 ' A' ' 34' ' ' ILE . 55.9 p -77.35 120.19 22.03 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 110.306 -3.134 . . . . 0.0 108.251 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -114.76 31.79 6.42 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -67.56 -47.91 45.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.918 159.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 61.3 Cg_endo -74.71 176.09 10.26 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.145 1.23 . . . . 0.0 110.036 165.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.56 27.61 1.56 Allowed Glycine 0 CA--C 1.548 2.12 0 C-N-CA 126.163 1.84 . . . . 0.0 114.226 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 2.5 m -53.18 133.5 51.03 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 127.042 2.137 . . . . 0.0 110.74 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HB2' HD13 ' A' ' 25' ' ' LEU . 77.1 Cg_exo -61.17 132.88 43.74 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 121.101 1.201 . . . . 0.0 110.033 169.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 22' ' ' PRO . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 2' ' ' THR . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' HD11 ' A' ' 35' ' ' ILE . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.498 ' CD2' HG12 ' A' ' 33' ' ' ILE . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.481 1.122 1 N-CA-C 125.654 5.427 . . . . 0.0 125.654 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 34' ' ' ILE . 81.4 p -101.55 60.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.429 -168.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.682 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 18' ' ' LEU . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 0.3 OUTLIER -112.41 23.42 13.62 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -53.94 -40.29 80.24 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 116.459 -1.734 . . . . 0.0 114.941 174.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.17 -68.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.752 1.635 . . . . 0.0 111.217 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.19 65.6 0.16 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 127.02 2.248 . . . . 0.0 112.343 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.347 16.2 m -147.14 -71.3 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.39 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 51.1 Cg_endo -82.2 61.72 7.83 Favored 'Trans proline' 0 CA--C 1.552 1.383 0 CA-C-N 121.994 1.748 . . . . 0.0 115.367 -164.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 17' ' ' ARG . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 2' ' ' THR . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' A' ' 33' ' ' ILE . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.682 HD21 ' NH1' ' A' ' 10' ' ' ARG 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.391 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 124.727 2.203 . . . . 0.0 116.045 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.844 HG22 HD13 ' A' ' 34' ' ' ILE . 19.9 p -110.85 73.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 110.736 -2.938 . . . . 0.0 108.323 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' HZ ' HD11 ' A' ' 34' ' ' ILE . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 6.5 mmm-85 -85.54 3.86 38.61 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.7 mt -51.2 -41.43 75.01 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 122.931 2.605 . . . . 0.0 114.667 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -67.89 -49.86 0.97 Allowed 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 121.581 1.521 . . . . 0.0 110.997 166.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.14 -33.65 5.47 Favored Glycine 0 N--CA 1.494 2.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.392 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.281 82.1 m -61.14 -70.39 0.45 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 127.214 2.206 . . . . 0.0 114.616 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.6 Cg_endo -81.0 71.81 6.86 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 CA-C-N 121.61 1.611 . . . . 0.0 115.578 -157.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 17' ' ' ARG . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 44' ' ' TYR . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 HG22 ' A' ' 2' ' ' THR . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' HD11 ' A' ' 35' ' ' ILE . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.491 1.618 1 N-CA-C 125.248 5.277 . . . . 0.0 125.248 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 34' ' ' ILE . 54.6 p -101.87 60.19 0.86 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.334 -169.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.683 ' CZ ' HD21 ' A' ' 46' ' ' ASN . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' HA ' HD23 ' A' ' 18' ' ' LEU . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 8.94 44.26 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -51.54 -41.42 76.95 Favored Pre-proline 0 N--CA 1.481 1.11 0 CA-C-O 116.303 -1.808 . . . . 0.0 114.446 167.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.38 -46.7 29.9 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.868 3.045 . . . . 0.0 115.054 170.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.84 4.82 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.582 1.563 . . . . 0.0 113.675 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.343 2.4 m -149.47 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -79.65 70.11 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 116.841 -159.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HE1' ' A' ' 44' ' ' TYR . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 2' ' ' THR . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.494 ' HE1' ' O ' ' A' ' 31' ' ' GLY . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.683 HD21 ' CZ ' ' A' ' 10' ' ' ARG . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 34' ' ' ILE . 75.5 p -79.45 130.52 35.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.382 -173.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 35' ' ' ILE . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' HH11 ' A' ' 10' ' ' ARG . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 HH11 ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 -97.07 40.71 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.9 mt -56.17 125.96 66.07 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 147.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 0.24 -65.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 2 C-N-CA 126.615 4.876 . . . . 0.0 124.098 -173.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.94 -32.24 83.34 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.462 1.03 . . . . 0.0 115.595 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -77.17 130.19 75.87 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 124.759 0.917 . . . . 0.0 113.058 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HB2' HD23 ' A' ' 25' ' ' LEU . 43.8 Cg_exo -68.69 141.26 49.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.136 1.891 . . . . 0.0 111.444 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 22' ' ' PRO . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 44' ' ' TYR . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 2' ' ' THR . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 3' ' ' CYS . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 122.165 0.983 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 34' ' ' ILE . 69.8 p -102.51 68.66 1.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 -168.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 6' ' ' SER . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HD2' ' HA2' ' A' ' 20' ' ' GLY 0.286 5.9 tpt180 -95.82 11.51 33.39 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.56 -43.03 97.53 Favored Pre-proline 0 N--CA 1.483 1.206 0 CA-C-O 116.422 -1.752 . . . . 0.0 113.437 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -57.34 -63.88 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.742 2.295 . . . . 0.0 112.671 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 17' ' ' ARG . . . 120.83 53.94 0.24 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 113.193 -1.821 . . . . 0.0 114.84 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.308 3.3 m -154.55 -69.28 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 117.474 -1.25 . . . . 0.0 113.546 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.668 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.2 Cg_endo -81.66 73.87 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.847 1.695 . . . . 0.0 114.282 -160.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 ' CD2' ' A' ' 44' ' ' TYR . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 2' ' ' THR . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' HG12 ' A' ' 33' ' ' ILE . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.51 HG22 HG12 ' A' ' 34' ' ' ILE . 60.2 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 35' ' ' ILE . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.47 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.744 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 17' ' ' ARG 0.864 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo . . . . . 0 CA--C 1.527 0.145 0 CA-C-O 121.582 0.576 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 44' ' ' TYR . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 2' ' ' THR . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.744 HD21 ' NH1' ' A' ' 10' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 123.669 1.7 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.687 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 56.3 Cg_endo . . . . . 0 CA--C 1.545 1.065 0 N-CA-C 115.476 1.299 . . . . 0.0 115.476 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 44' ' ' TYR . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.479 HG22 HG12 ' A' ' 34' ' ' ILE . 55.9 p . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 122.365 1.079 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 . . . . . 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HB2' HD13 ' A' ' 25' ' ' LEU . 77.1 Cg_exo . . . . . 0 N--CA 1.482 0.823 0 N-CA-C 110.033 -0.795 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 22' ' ' PRO . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 2' ' ' THR . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' HD11 ' A' ' 35' ' ' ILE . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.498 ' CD2' HG12 ' A' ' 33' ' ' ILE . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 34' ' ' ILE . 81.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 123.721 1.724 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.682 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 51.1 Cg_endo . . . . . 0 CA--C 1.552 1.383 0 N-CA-C 115.367 1.257 . . . . 0.0 115.367 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.625 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 17' ' ' ARG . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 2' ' ' THR . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' A' ' 33' ' ' ILE . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.682 HD21 ' NH1' ' A' ' 10' ' ' ARG 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.844 HG22 HD13 ' A' ' 34' ' ' ILE . 19.9 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 125.653 2.644 . . . . 0.0 108.323 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.525 ' HZ ' HD11 ' A' ' 34' ' ' ILE . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 6.5 mmm-85 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.6 Cg_endo . . . . . 0 CA--C 1.547 1.143 0 N-CA-C 115.578 1.338 . . . . 0.0 115.578 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 17' ' ' ARG . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 44' ' ' TYR . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 HG22 ' A' ' 2' ' ' THR . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' HD11 ' A' ' 35' ' ' ILE . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 34' ' ' ILE . 54.6 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 124.092 1.901 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.683 ' CZ ' HD21 ' A' ' 46' ' ' ASN . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 61.2 Cg_endo . . . . . 0 CA--C 1.536 0.603 0 N-CA-C 116.841 1.823 . . . . 0.0 116.841 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HE1' ' A' ' 44' ' ' TYR . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 2' ' ' THR . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.494 ' HE1' ' O ' ' A' ' 31' ' ' GLY . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.683 HD21 ' CZ ' ' A' ' 10' ' ' ARG . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 34' ' ' ILE . 75.5 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.03 0.443 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 35' ' ' ILE . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' HH11 ' A' ' 10' ' ' ARG . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 HH11 ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HB2' HD23 ' A' ' 25' ' ' LEU . 43.8 Cg_exo . . . . . 0 CA--C 1.542 0.885 0 CA-C-O 122.388 0.912 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 22' ' ' PRO . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 44' ' ' TYR . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 2' ' ' THR . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 3' ' ' CYS . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 34' ' ' ILE . 69.8 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 HD21 ' A' ' 46' ' ' ASN . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 6' ' ' SER . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HD3' ' OE2' ' A' ' 23' ' ' GLU 0.286 5.9 tpt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.668 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.2 Cg_endo . . . . . 0 CA--C 1.541 0.857 0 N-CA-C 114.282 0.839 . . . . 0.0 114.282 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 ' CD2' ' A' ' 44' ' ' TYR . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 2' ' ' THR . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' HG12 ' A' ' 33' ' ' ILE . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.402 HD21 HG13 ' A' ' 7' ' ' ILE . 19.5 m120 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.51 HG22 HG12 ' A' ' 34' ' ' ILE . 60.2 p -77.36 51.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 112.026 -2.352 . . . . 0.0 114.938 -165.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 35' ' ' ILE . 70.1 m -61.25 116.3 4.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.374 -172.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 19.3 m -116.57 138.37 24.41 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -171.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 90.3 Cg_endo -72.96 -1.79 11.02 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 N-CA-C 116.405 1.656 . . . . 0.0 116.405 -172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 p -156.85 167.67 29.77 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.061 0.846 . . . . 0.0 108.973 167.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -68.68 -23.35 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 125.724 1.609 . . . . 0.0 112.186 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 t -79.75 -40.58 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 -34.55 75.93 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.744 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -70.04 -41.76 73.81 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.422 1.076 . . . . 0.0 112.359 169.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.8 p -59.9 -45.05 93.78 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.201 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -63.95 -37.47 87.53 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.202 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -60.04 -45.71 91.92 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.918 1.287 . . . . 0.0 109.156 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 117.647 -1.168 . . . . 0.0 112.102 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.549 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 59.7 t -67.77 -38.58 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 170.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.372 10.7 t -48.5 -40.56 27.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.547 1.521 . . . . 0.0 114.094 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD2' ' C ' ' A' ' 17' ' ' ARG 0.864 0.0 OUTLIER -57.25 -24.17 52.94 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 169.82 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.267 30.8 mt -71.17 -59.79 3.14 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-O 115.814 -2.041 . . . . 0.0 112.776 172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 15' ' ' VAL . 50.8 Cg_endo -81.71 -69.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.445 2.096 . . . . 0.0 114.124 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.22 37.47 2.19 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 127.392 2.425 . . . . 0.0 112.444 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ARG 0.384 56.1 m -8.51 -71.71 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 129.472 3.109 . . . . 0.0 115.594 173.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -50.2 131.19 30.54 Favored 'Trans proline' 0 C--N 1.352 0.716 0 CA-C-N 122.327 1.867 . . . . 0.0 112.449 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -55.23 -31.97 61.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 114.331 -1.304 . . . . 0.0 114.145 -170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.96 70.78 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.86 -44.06 97.58 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.439 0.462 . . . . 0.0 111.711 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.61 -42.67 79.15 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 116.252 -1.833 . . . . 0.0 109.897 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -45.71 93.21 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 60.0 p -64.45 -32.42 74.05 Favored 'General case' 0 N--CA 1.511 2.607 0 O-C-N 125.334 1.647 . . . . 0.0 111.056 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.353 8.7 m-85 -88.61 -42.08 12.25 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.445 1.498 . . . . 0.0 114.461 -174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 p -106.98 11.54 29.7 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 121.565 1.984 . . . . 0.0 115.433 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.79 52.28 49.59 Favored Glycine 0 N--CA 1.48 1.598 0 O-C-N 123.986 0.804 . . . . 0.0 111.186 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.3 m -113.5 161.56 17.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 44' ' ' TYR . 47.0 pt -122.35 111.68 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.098 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.51 HG12 HG22 ' A' ' 2' ' ' THR . 6.8 mt -79.14 107.72 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 3' ' ' CYS . 1.9 pp -121.38 129.25 25.32 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-O 118.99 -0.529 . . . . 0.0 112.315 -171.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 11.9 Cg_exo -38.71 -38.51 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.682 1 C-N-CA 125.498 4.132 . . . . 0.0 120.548 -174.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 162.15 7.56 Favored Glycine 0 N--CA 1.484 1.866 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.535 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.91 9.98 42.34 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.64 170.54 15.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 113.703 -1.59 . . . . 0.0 108.549 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 90.3 m -102.69 142.38 24.46 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 111.777 -2.465 . . . . 0.0 114.41 -167.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 88.8 Cg_exo -53.73 152.49 22.11 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.962 3.775 . . . . 0.0 110.286 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.76 -22.46 33.46 Favored Glycine 0 N--CA 1.488 2.122 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.948 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -107.22 0.41 23.24 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 4.9 m-85 -133.08 30.96 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.976 0.511 . . . . 0.0 111.165 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.01 86.74 2.36 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.744 HD21 ' NH1' ' A' ' 10' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 129.099 2.96 . . . . 0.0 114.142 174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' ALA . 48.4 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 120.446 3.499 . . . . 0.0 120.446 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.421 ' H ' ' HB ' ' A' ' 1' ' ' THR . 65.5 p -89.45 59.47 4.81 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.99 2.116 . . . . 0.0 111.851 -169.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.0 m -68.94 112.63 5.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.702 -167.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 61.6 m -113.34 143.45 29.33 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -173.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 42.2 Cg_endo -87.81 -46.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 N-CA-C 116.294 1.613 . . . . 0.0 116.294 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 p -108.67 41.34 1.61 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.738 2.495 . . . . 0.0 117.738 -160.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.322 1.0 OUTLIER 47.84 -41.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 131.69 3.996 . . . . 0.0 119.301 175.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.17 -35.38 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 127.947 2.499 . . . . 0.0 104.947 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.9 74.53 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -72.12 -46.25 57.35 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.013 0.821 . . . . 0.0 112.394 171.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -59.69 -41.04 89.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -66.45 -37.17 84.55 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.771 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.46 -45.51 88.47 Favored 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 124.776 1.23 . . . . 0.0 108.349 173.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -64.19 -32.91 74.67 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 127.326 2.25 . . . . 0.0 111.829 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.13 -41.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.84 -29.15 39.71 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.081 0.855 . . . . 0.0 111.764 168.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.543 3.1 tpt85 -105.39 16.5 25.48 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt -60.17 -40.16 74.92 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.52 -44.57 34.53 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.174 2.582 . . . . 0.0 115.803 169.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.76 45.88 5.89 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 125.368 1.461 . . . . 0.0 111.476 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.323 2.9 m -148.78 -68.39 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.377 -1.297 . . . . 0.0 113.114 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.687 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -81.67 62.87 8.39 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 CA-C-N 122.348 1.874 . . . . 0.0 115.476 -162.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -55.86 -44.74 78.36 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.73 0.812 . . . . 0.0 112.08 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.45 -31.59 62.31 Favored 'General case' 0 N--CA 1.513 2.702 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.687 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 73.7 mt -64.98 -36.17 83.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.079 0.862 . . . . 0.0 111.556 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.9 m -56.43 -43.32 79.3 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 116.06 -1.924 . . . . 0.0 110.029 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.16 -47.8 84.53 Favored 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 p -63.14 -40.98 99.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 125.008 1.442 . . . . 0.0 110.725 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.315 12.6 m-85 -78.31 -37.35 44.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.6 p -113.93 12.3 18.05 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.76 55.2 26.21 Favored Glycine 0 CA--C 1.544 1.866 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.196 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.1 m -118.63 162.07 19.01 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 44' ' ' TYR . 3.1 pt -120.06 108.44 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.363 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.61 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.9 mt -82.32 107.7 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.6 pp -125.26 131.36 24.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -166.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 88.4 Cg_exo -51.83 -28.85 32.32 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 124.806 3.671 . . . . 0.0 118.316 -173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -45.39 -20.41 0.33 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.028 2.251 . . . . 0.0 117.675 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 1' ' ' THR . . . 73.5 -0.64 3.3 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 128.526 2.731 . . . . 0.0 114.758 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.52 168.57 23.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.405 -2.179 . . . . 0.0 108.417 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 83.2 m -105.1 143.55 26.97 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-N 111.569 -2.56 . . . . 0.0 115.179 -163.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 72.9 Cg_exo -58.89 153.21 52.32 Favored 'Trans proline' 0 N--CA 1.48 0.704 1 C-N-CA 125.523 4.148 . . . . 0.0 110.039 171.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.26 -24.23 36.19 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.618 1.104 . . . . 0.0 115.478 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -103.37 -4.53 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 10.3 m-85 -126.7 28.81 5.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.499 0.499 . . . . 0.0 111.22 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.2 82.14 1.64 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 119.689 3.218 . . . . 0.0 119.689 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 112.015 -2.357 . . . . 0.0 111.933 177.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 118.362 2.727 . . . . 0.0 118.362 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.479 HG22 HG12 ' A' ' 34' ' ' ILE . 55.9 p -77.35 120.19 22.03 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 110.306 -3.134 . . . . 0.0 108.251 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 38.3 m -133.46 122.19 23.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.12 -172.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.0 m -120.71 135.7 24.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.125 -1.398 . . . . 0.0 107.257 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.93 -15.58 10.48 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 N-CA-C 115.911 1.466 . . . . 0.0 115.911 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.4 p -136.18 157.7 46.19 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mt -71.73 -20.34 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.88 -38.56 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.71 -38.25 76.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.361 -0.837 . . . . 0.0 112.067 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -38.92 83.69 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.64 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.2 p -61.96 -46.48 89.08 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.457 0.571 . . . . 0.0 111.472 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -57.51 -41.56 81.03 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.496 1.118 . . . . 0.0 111.262 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -63.6 -45.03 92.22 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.849 1.26 . . . . 0.0 109.809 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -73.98 -23.66 59.5 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 116.697 -1.621 . . . . 0.0 112.279 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.59 -41.77 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 170.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.2 t -49.54 -33.82 15.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 123.579 0.549 . . . . 0.0 111.801 168.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -114.76 31.79 6.42 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 18' ' ' LEU . 73.3 mt -67.56 -47.91 45.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.918 159.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HG2' ' OG1' ' A' ' 21' ' ' THR . 61.3 Cg_endo -74.71 176.09 10.26 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.145 1.23 . . . . 0.0 110.036 165.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.56 27.61 1.56 Allowed Glycine 0 CA--C 1.548 2.12 0 C-N-CA 126.163 1.84 . . . . 0.0 114.226 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 2.5 m -53.18 133.5 51.03 Favored Pre-proline 0 N--CA 1.488 1.435 0 C-N-CA 127.042 2.137 . . . . 0.0 110.74 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HB2' HD13 ' A' ' 25' ' ' LEU . 77.1 Cg_exo -61.17 132.88 43.74 Favored 'Trans proline' 0 N--CA 1.482 0.823 0 C-N-CA 121.101 1.201 . . . . 0.0 110.033 169.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -49.86 -35.22 22.5 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 126.216 1.806 . . . . 0.0 112.627 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.55 78.05 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 22' ' ' PRO . 9.4 mp -60.03 -44.17 94.8 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.645 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.0 m -57.7 -42.61 84.07 Favored 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 117.341 -1.314 . . . . 0.0 110.708 171.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.81 93.0 Favored 'General case' 0 N--CA 1.525 3.313 0 CA-C-N 121.292 1.86 . . . . 0.0 115.512 172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -67.14 -46.97 72.46 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.313 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.254 7.5 m-85 -72.67 -35.02 67.6 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 126.658 1.983 . . . . 0.0 115.824 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.462 3.0 t -143.5 50.1 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 53.86 66.21 2.92 Favored Glycine 0 N--CA 1.491 2.342 0 CA-C-N 111.062 -2.79 . . . . 0.0 115.156 160.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.7 m -140.03 168.15 20.48 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.0 pt -122.23 138.09 53.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 113.213 -1.812 . . . . 0.0 111.913 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 HG12 HG22 ' A' ' 2' ' ' THR . 79.1 mt -110.26 112.31 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -128.7 137.58 31.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.336 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -56.87 -65.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 121.706 1.604 . . . . 0.0 111.622 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 55.23 -61.22 0.01 OUTLIER Glycine 0 N--CA 1.482 1.711 0 C-N-CA 127.799 2.618 . . . . 0.0 118.153 168.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 111.41 -16.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 1 C-N-CA 132.555 4.342 . . . . 0.0 112.259 -169.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.76 172.55 15.07 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.522 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 95.6 m -82.23 141.1 45.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.494 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' HD11 ' A' ' 35' ' ' ILE . 87.8 Cg_exo -54.09 150.3 32.17 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 124.579 3.519 . . . . 0.0 109.335 172.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -54.81 -22.74 27.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.276 1.417 . . . . 0.0 115.058 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -104.42 -2.26 25.64 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.498 ' CD2' HG12 ' A' ' 33' ' ' ILE . 7.5 m-85 -129.46 23.47 5.5 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.831 0.707 . . . . 0.0 111.785 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.75 43.7 1.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 125.916 2.769 . . . . 0.0 117.844 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 110.93 -2.85 . . . . 0.0 111.252 -177.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.481 1.122 1 N-CA-C 125.654 5.427 . . . . 0.0 125.654 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.43 HG22 HG12 ' A' ' 34' ' ' ILE . 81.4 p -101.55 60.09 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.429 -168.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.1 m -66.19 117.56 8.66 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 110.589 -3.005 . . . . 0.0 111.872 -168.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -118.98 137.81 25.46 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.2 0.75 9.42 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 N-CA-C 116.641 1.747 . . . . 0.0 116.641 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 p -155.31 165.45 36.6 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.53 -24.93 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.976 0.91 . . . . 0.0 109.698 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 t -79.63 -40.94 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.03 -36.68 78.02 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 121.224 -0.923 . . . . 0.0 112.796 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.682 ' NH1' HD21 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.98 -40.62 83.07 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.326 171.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.1 p -59.29 -45.11 92.16 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.774 0.716 . . . . 0.0 110.181 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -65.14 -40.3 94.23 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.473 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.62 -45.34 89.4 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.399 1.08 . . . . 0.0 108.491 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.281 57.8 m-20 -73.4 -28.34 61.95 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.061 0.945 . . . . 0.0 111.217 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 ' HA ' HD23 ' A' ' 18' ' ' LEU . 65.8 t -68.58 -41.85 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.6 t -54.69 -26.98 36.99 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 119.334 0.97 . . . . 0.0 113.079 170.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 26' ' ' CYS . 0.3 OUTLIER -112.41 23.42 13.62 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -53.94 -40.29 80.24 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 116.459 -1.734 . . . . 0.0 114.941 174.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -67.17 -68.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.752 1.635 . . . . 0.0 111.217 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.19 65.6 0.16 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 127.02 2.248 . . . . 0.0 112.343 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.347 16.2 m -147.14 -71.3 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.381 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.39 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 51.1 Cg_endo -82.2 61.72 7.83 Favored 'Trans proline' 0 CA--C 1.552 1.383 0 CA-C-N 121.994 1.748 . . . . 0.0 115.367 -164.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -40.33 67.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.213 1.005 . . . . 0.0 112.456 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.57 -32.97 58.48 Favored 'General case' 0 N--CA 1.517 2.923 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 94.5 mt -64.28 -36.05 82.85 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.714 0.634 . . . . 0.0 111.198 171.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HG2' ' A' ' 17' ' ' ARG . 37.2 m -57.34 -42.83 82.69 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 116.071 -1.919 . . . . 0.0 110.517 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -48.1 82.48 Favored 'General case' 0 N--CA 1.532 3.637 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.9 m -63.55 -41.19 98.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.639 1.212 . . . . 0.0 111.22 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.269 9.2 m-85 -79.08 -33.08 44.83 Favored 'General case' 0 N--CA 1.519 3.019 0 C-N-CA 125.519 1.527 . . . . 0.0 114.298 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.3 p -113.58 3.04 15.52 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.98 49.9 55.6 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.9 m -114.53 162.16 17.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 44' ' ' TYR . 46.1 pt -118.65 120.85 65.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 112.471 -2.15 . . . . 0.0 112.135 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG12 HG22 ' A' ' 2' ' ' THR . 70.1 mt -91.35 112.57 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 pp -125.28 135.03 26.33 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 124.415 1.086 . . . . 0.0 110.266 -169.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 84.4 Cg_exo -49.62 -30.32 21.65 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.495 3.463 . . . . 0.0 115.83 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.65 124.89 21.08 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.766 2.127 . . . . 0.0 109.317 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.03 -7.71 53.47 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.554 1.168 . . . . 0.0 113.917 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.273 0.6 OUTLIER -130.25 165.96 21.32 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.627 168.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 84.7 m -97.47 143.19 25.74 Favored Pre-proline 0 C--O 1.244 0.805 0 CA-C-N 111.827 -2.442 . . . . 0.0 112.981 -170.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 84.9 Cg_exo -48.85 149.66 7.46 Favored 'Trans proline' 0 CA--C 1.536 0.604 1 C-N-CA 125.34 4.026 . . . . 0.0 111.236 171.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.25 -25.35 47.67 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 114.926 -1.034 . . . . 0.0 114.003 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -103.57 -3.43 25.25 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.411 ' CD2' HG12 ' A' ' 33' ' ' ILE . 4.9 m-85 -128.57 25.37 5.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.985 0.803 . . . . 0.0 111.324 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.56 78.43 1.16 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 123.961 1.839 . . . . 0.0 114.945 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.682 HD21 ' NH1' ' A' ' 10' ' ' ARG 0.26 90.6 m-20 . . . . . 0 CA--C 1.56 1.329 0 CA-C-N 110.403 -3.09 . . . . 0.0 115.542 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . 0.391 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.06 0 CA-C-O 124.727 2.203 . . . . 0.0 116.045 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.844 HG22 HD13 ' A' ' 34' ' ' ILE . 19.9 p -110.85 73.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 110.736 -2.938 . . . . 0.0 108.323 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 13.8 m -80.75 122.98 27.82 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.035 -3.711 . . . . 0.0 110.36 -164.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 22.6 m -130.74 135.49 27.44 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -79.96 -9.12 14.34 Favored 'Trans proline' 0 N--CA 1.474 0.361 0 N-CA-C 116.814 1.813 . . . . 0.0 116.814 -172.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.5 p -143.91 160.24 41.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.834 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -70.97 -17.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.455 0.702 . . . . 0.0 109.55 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.25 -42.04 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -37.15 75.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.765 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -66.21 -38.94 89.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 169.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -57.64 -44.47 85.64 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.086 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.05 -39.86 90.47 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.576 1.15 . . . . 0.0 111.955 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.525 ' HZ ' HD11 ' A' ' 34' ' ' ILE . 31.1 t80 -59.95 -43.54 94.96 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.064 1.746 . . . . 0.0 108.724 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -69.42 -31.93 70.59 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 127.113 2.165 . . . . 0.0 111.909 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.73 -37.35 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.2 t -60.45 -24.54 65.31 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 119.105 0.866 . . . . 0.0 111.524 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 6.5 mmm-85 -85.54 3.86 38.61 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 116.512 -1.708 . . . . 0.0 111.18 172.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.7 mt -51.2 -41.43 75.01 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 122.931 2.605 . . . . 0.0 114.667 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -67.89 -49.86 0.97 Allowed 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 121.581 1.521 . . . . 0.0 110.997 166.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.14 -33.65 5.47 Favored Glycine 0 N--CA 1.494 2.505 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.392 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.281 82.1 m -61.14 -70.39 0.45 Allowed Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 127.214 2.206 . . . . 0.0 114.616 -174.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.6 Cg_endo -81.0 71.81 6.86 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 CA-C-N 121.61 1.611 . . . . 0.0 115.578 -157.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 17' ' ' ARG . 47.9 mt-10 -53.37 -48.84 68.24 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.704 1.202 . . . . 0.0 112.714 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.07 64.79 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 74.9 mt -66.42 -36.17 82.15 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.243 171.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m -56.85 -44.46 82.17 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.279 167.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.71 -48.4 80.95 Favored 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 p -63.71 -40.41 96.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.368 1.042 . . . . 0.0 110.572 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -75.2 -33.45 61.41 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-O 117.621 -1.181 . . . . 0.0 113.578 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -117.73 13.18 14.13 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -166.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.48 40.45 96.23 Favored Glycine 0 CA--C 1.548 2.138 0 C-N-CA 123.941 0.781 . . . . 0.0 111.427 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.4 m -110.35 161.09 15.98 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 44' ' ' TYR . 50.8 pt -122.91 100.51 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.153 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 HG22 ' A' ' 2' ' ' THR . 2.1 mm -70.25 95.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 105.545 -2.021 . . . . 0.0 105.545 168.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 ' HD3' ' A' ' 41' ' ' PRO . 2.2 pp -113.03 102.63 55.07 Favored Pre-proline 0 N--CA 1.487 1.4 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.408 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 58.4 Cg_endo -64.96 173.09 6.26 Favored 'Trans proline' 0 CA--C 1.553 1.446 0 C-N-CA 122.448 2.099 . . . . 0.0 111.039 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.57 -132.52 9.55 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 106.271 -2.732 . . . . 0.0 106.271 -170.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.81 -33.44 4.8 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.35 174.66 15.08 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.112 1.434 . . . . 0.0 112.38 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.5 m -84.76 144.52 42.41 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 110.022 -3.263 . . . . 0.0 112.466 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' HD11 ' A' ' 35' ' ' ILE . 83.9 Cg_exo -56.04 152.28 37.85 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.172 3.248 . . . . 0.0 110.601 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.03 -21.43 38.29 Favored Glycine 0 CA--C 1.545 1.94 0 C-N-CA 125.694 1.616 . . . . 0.0 114.732 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -104.28 -0.47 28.24 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 8.8 m-85 -130.48 19.36 5.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 123.556 0.535 . . . . 0.0 111.946 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.21 50.4 1.26 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 119.556 3.169 . . . . 0.0 119.556 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.4 m120 . . . . . 0 C--O 1.257 1.496 0 CA-C-N 110.524 -3.035 . . . . 0.0 111.415 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 65.6 p . . . . . 0 N--CA 1.491 1.618 1 N-CA-C 125.248 5.277 . . . . 0.0 125.248 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 HG12 ' A' ' 34' ' ' ILE . 54.6 p -101.87 60.19 0.86 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.334 -169.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.2 m -65.25 116.02 6.17 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 110.483 -3.053 . . . . 0.0 111.609 -171.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -120.29 140.04 29.5 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -164.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -58.76 -21.82 58.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.274 2.65 . . . . 0.0 117.109 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 p -153.9 170.25 21.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.925 0.784 . . . . 0.0 109.117 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -65.89 -27.76 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.489 0.716 . . . . 0.0 109.202 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.01 -40.8 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.19 73.2 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.887 -0.508 . . . . 0.0 112.028 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.683 ' CZ ' HD21 ' A' ' 46' ' ' ASN . 7.5 tpp85 -66.78 -39.24 87.75 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.652 0.595 . . . . 0.0 112.472 168.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.6 m -58.35 -41.6 85.05 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.925 0.766 . . . . 0.0 110.547 172.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -67.55 -40.05 84.95 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.734 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -54.74 -44.87 73.95 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.173 0.989 . . . . 0.0 109.873 170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -66.68 -35.28 79.76 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.873 1.669 . . . . 0.0 111.894 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' HA ' HD23 ' A' ' 18' ' ' LEU . 48.5 t -73.21 -41.56 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.604 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.9 -25.14 64.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 120.333 1.424 . . . . 0.0 111.652 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 8.94 44.26 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.106 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -51.54 -41.42 76.95 Favored Pre-proline 0 N--CA 1.481 1.11 0 CA-C-O 116.303 -1.808 . . . . 0.0 114.446 167.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.38 -46.7 29.9 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.868 3.045 . . . . 0.0 115.054 170.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.84 4.82 Favored Glycine 0 CA--C 1.545 1.95 0 C-N-CA 125.582 1.563 . . . . 0.0 113.675 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.343 2.4 m -149.47 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -171.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -79.65 70.11 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.646 2.231 . . . . 0.0 116.841 -159.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -60.64 -41.6 95.26 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.57 -33.69 64.77 Favored 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 113.273 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 79.3 mt -68.46 -42.97 78.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 123.909 0.756 . . . . 0.0 111.628 176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.4 m -59.98 -53.73 54.45 Favored 'General case' 0 N--CA 1.512 2.67 0 CA-C-O 116.446 -1.74 . . . . 0.0 109.173 169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.45 68.39 Favored 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 m -64.74 -53.69 43.2 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 125.424 1.703 . . . . 0.0 108.524 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -82.13 -29.31 31.72 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.1 p -96.56 9.47 41.38 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 120.122 1.328 . . . . 0.0 112.193 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HE1' ' A' ' 44' ' ' TYR . . . 56.27 44.74 89.29 Favored Glycine 0 CA--C 1.539 1.573 0 O-C-N 124.654 1.221 . . . . 0.0 111.798 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -102.1 158.02 16.46 Favored 'General case' 0 N--CA 1.516 2.871 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.29 18.1 pt -116.06 123.21 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 111.825 -2.443 . . . . 0.0 112.288 171.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 2' ' ' THR . 81.0 mt -96.46 105.41 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -116.0 144.8 33.49 Favored Pre-proline 0 N--CA 1.485 1.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -176.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.71 -30.06 27.82 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.871 3.047 . . . . 0.0 114.808 173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -46.45 126.98 9.76 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 126.201 2.188 . . . . 0.0 111.09 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.72 -16.85 64.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 111.836 -2.182 . . . . 0.0 112.521 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.278 0.6 OUTLIER -137.9 171.33 14.58 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.367 1.079 . . . . 0.0 111.324 175.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.6 m -91.33 143.09 27.73 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 111.039 -2.801 . . . . 0.0 113.999 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.1 163.17 33.34 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 123.367 2.711 . . . . 0.0 108.936 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.31 -20.64 10.6 Favored Glycine 0 CA--C 1.544 1.889 0 CA-C-N 113.525 -1.67 . . . . 0.0 114.159 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -105.64 -6.41 19.25 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.494 ' HE1' ' O ' ' A' ' 31' ' ' GLY . 42.3 m-85 -125.94 26.64 6.53 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.83 92.38 8.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.683 HD21 ' CZ ' ' A' ' 10' ' ' ARG . 2.2 m-20 . . . . . 0 N--CA 1.483 1.222 0 C-N-CA 127.994 2.518 . . . . 0.0 113.589 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 117.365 2.358 . . . . 0.0 117.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 34' ' ' ILE . 75.5 p -79.45 130.52 35.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 111.807 -2.451 . . . . 0.0 111.382 -173.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 35' ' ' ILE . 50.9 m -140.45 125.67 18.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.35 1.86 . . . . 0.0 110.374 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' HB2' HH11 ' A' ' 10' ' ' ARG . 56.9 m -115.53 145.78 35.2 Favored Pre-proline 0 N--CA 1.499 2.008 0 C-N-CA 125.84 1.656 . . . . 0.0 107.349 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 43.9 Cg_endo -82.99 -15.48 8.04 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 121.834 1.69 . . . . 0.0 116.412 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.4 p -138.96 157.91 45.15 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.957 1.708 . . . . 0.0 108.696 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.97 -18.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.045 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.37 -41.48 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.49 74.39 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.736 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 HH11 ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.92 -36.9 80.95 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 171.067 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -59.7 -52.45 65.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.334 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -60.14 -36.21 77.01 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.49 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -62.93 -48.07 80.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.513 1.125 . . . . 0.0 109.672 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -72.27 -26.9 62.17 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.742 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.0 -40.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.354 31.8 t -52.15 -44.37 64.55 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.689 167.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.317 4.2 ttp180 -97.07 40.71 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.639 1.176 . . . . 0.0 112.794 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.9 mt -56.17 125.96 66.07 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 147.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER 0.24 -65.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.88 2 C-N-CA 126.615 4.876 . . . . 0.0 124.098 -173.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.94 -32.24 83.34 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.462 1.03 . . . . 0.0 115.595 -171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -77.17 130.19 75.87 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 124.759 0.917 . . . . 0.0 113.058 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HB2' HD23 ' A' ' 25' ' ' LEU . 43.8 Cg_exo -68.69 141.26 49.28 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.136 1.891 . . . . 0.0 111.444 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.4 -37.74 62.78 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.189 -2.278 . . . . 0.0 113.675 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 22' ' ' PRO . 4.4 mm? -64.44 -42.36 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.376 0.607 . . . . 0.0 110.589 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -55.72 -39.66 71.39 Favored 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 116.116 -1.897 . . . . 0.0 109.934 168.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.58 -46.75 81.4 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.9 p -64.52 -41.31 96.47 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 125.427 1.705 . . . . 0.0 110.041 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.311 11.2 m-85 -78.66 -35.58 45.09 Favored 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 126.35 1.86 . . . . 0.0 113.741 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -111.49 0.86 16.65 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.28 56.11 9.29 Favored Glycine 0 N--CA 1.483 1.808 0 CA-C-O 121.754 0.641 . . . . 0.0 112.217 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.2 m -125.95 166.39 17.01 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 HG12 ' CD2' ' A' ' 44' ' ' TYR . 45.9 pt -125.46 151.33 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 112.832 -1.985 . . . . 0.0 112.966 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 2' ' ' THR . 95.8 mt -115.95 126.51 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 3' ' ' CYS . 7.6 mt -107.18 139.44 20.47 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.46 -29.76 60.79 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.445 2.097 . . . . 0.0 115.735 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -64.49 -166.48 1.17 Allowed Glycine 0 N--CA 1.476 1.341 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.319 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.22 11.88 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.17 172.06 13.24 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 122.77 1.272 . . . . 0.0 110.46 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.2 m -109.97 140.94 22.8 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 111.289 -2.687 . . . . 0.0 112.258 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 49.5 Cg_endo -72.15 163.02 40.0 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.198 2.598 . . . . 0.0 110.514 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.74 -21.2 14.75 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 113.597 -1.638 . . . . 0.0 115.256 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -101.08 -10.78 20.17 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.495 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 11.1 m-85 -129.15 26.87 5.43 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.09 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.22 105.22 12.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.26 1.643 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.575 -175.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 122.165 0.983 . . . . 0.0 113.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 34' ' ' ILE . 69.8 p -102.51 68.66 1.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 124.849 2.261 . . . . 0.0 111.557 -168.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.59 116.06 13.71 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 110.407 -3.088 . . . . 0.0 110.252 -172.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' SG ' ' HD3' ' A' ' 10' ' ' ARG . 26.5 m -121.47 137.71 27.32 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 42.0 Cg_endo -88.31 6.98 4.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.505 2.136 . . . . 0.0 115.944 -172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 9' ' ' ALA . 29.4 t -148.99 153.16 37.53 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 HD21 ' A' ' 46' ' ' ASN . 4.0 mt -63.01 -31.83 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.147 0.979 . . . . 0.0 109.268 169.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.55 -39.02 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 6' ' ' SER . . . -70.58 -36.22 73.45 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HD3' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -69.64 -36.31 76.0 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.1 m -57.3 -48.46 78.87 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.951 0.405 . . . . 0.0 111.548 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -60.61 -41.37 94.66 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 125.082 1.353 . . . . 0.0 110.674 171.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -62.37 -45.78 91.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.059 0.944 . . . . 0.0 109.098 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -60.96 -33.56 73.39 Favored 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 128.109 2.564 . . . . 0.0 111.873 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.63 -39.79 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.27 39.3 t -58.12 -30.82 66.62 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.728 1.149 . . . . 0.0 112.776 169.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HD2' ' HA2' ' A' ' 20' ' ' GLY 0.286 5.9 tpt180 -95.82 11.51 33.39 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 176.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.56 -43.03 97.53 Favored Pre-proline 0 N--CA 1.483 1.206 0 CA-C-O 116.422 -1.752 . . . . 0.0 113.437 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -57.34 -63.88 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.742 2.295 . . . . 0.0 112.671 170.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 17' ' ' ARG . . . 120.83 53.94 0.24 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-N 113.193 -1.821 . . . . 0.0 114.84 177.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.308 3.3 m -154.55 -69.28 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.927 0 CA-C-O 117.474 -1.25 . . . . 0.0 113.546 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.668 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 57.2 Cg_endo -81.66 73.87 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 CA-C-N 121.847 1.695 . . . . 0.0 114.282 -160.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 7.5 mm-40 -57.76 -46.73 84.11 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.334 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.51 -31.85 69.1 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 22' ' ' PRO . 3.8 mm? -66.66 -38.92 87.83 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.073 173.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.14 -42.65 73.31 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.326 167.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.23 92.32 Favored 'General case' 0 N--CA 1.517 2.896 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 171.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.2 p -70.72 -53.72 14.53 Favored 'General case' 0 N--CA 1.529 3.478 0 O-C-N 124.18 0.925 . . . . 0.0 110.252 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . 0.277 8.7 m-85 -62.55 -32.39 73.34 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.453 2.301 . . . . 0.0 113.664 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.454 1.2 t -145.19 49.12 1.27 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.03 64.77 2.57 Favored Glycine 0 N--CA 1.488 2.108 0 CA-C-N 111.705 -2.498 . . . . 0.0 115.713 162.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.2 m -135.18 166.44 23.09 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG12 ' CD2' ' A' ' 44' ' ' TYR . 48.5 pt -120.23 103.21 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 111.974 -2.376 . . . . 0.0 112.02 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 2' ' ' THR . 4.4 mt -73.51 111.05 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 1.3 pt -124.76 124.73 25.54 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.438 -174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 35' ' ' ILE . 9.2 Cg_endo -48.04 -46.57 21.75 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.865 3.043 . . . . 0.0 118.712 -174.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.35 48.3 0.08 OUTLIER Glycine 0 N--CA 1.491 2.35 0 C-N-CA 127.648 2.547 . . . . 0.0 118.121 -171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.21 -29.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . 0.262 0.6 OUTLIER -130.72 165.91 21.88 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.738 1.256 . . . . 0.0 110.441 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.1 m -98.7 145.53 30.07 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.041 -2.345 . . . . 0.0 114.422 -169.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -55.33 148.02 53.26 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 124.407 3.405 . . . . 0.0 109.625 168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.34 -22.84 31.88 Favored Glycine 0 CA--C 1.55 2.266 0 C-N-CA 125.17 1.366 . . . . 0.0 114.6 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -103.87 0.52 30.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' HG12 ' A' ' 33' ' ' ILE . 10.6 m-85 -129.46 29.32 5.1 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.258 0.623 . . . . 0.0 111.202 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . 0.317 . . -91.07 35.75 0.91 Allowed 'General case' 0 C--N 1.327 -0.395 1 N-CA-C 123.072 4.471 . . . . 0.0 123.072 -175.058 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.402 HD21 HG13 ' A' ' 7' ' ' ILE . 19.5 m120 . . . . . 0 N--CA 1.488 1.446 0 CA-C-N 112.658 -2.064 . . . . 0.0 109.71 171.747 . . . . . . . . 1 1 . 1 stop_ save_